Last reviewed · How we verify
NCT05518513
Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty
NA trial testing Bupivacain in Arthroplasty, Replacement, Knee in 66 participants. Currently enrolling.
30 June 2024
Quick facts
| Lead sponsor | National Cheng-Kung University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 1 November 2022 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Bupivacain — full drug profile →
Conditions studied
- Arthroplasty, Replacement, Knee — all drugs for Arthroplasty, Replacement, Knee →
- Adductor Canal Block — all drugs for Adductor Canal Block →
Sponsor
National Cheng-Kung University Hospital
Who can join
20 and older, any sex, with Arthroplasty, Replacement, Knee or Adductor Canal Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators believed the analgesic efficacy of adductor canal block on patients receiving total knee arthroplasty. However, the analgesic effects of different delivery regimens and duration of effects are variable. The investigators hypothesize that using continuous infusion and shorter interval bolus of local anesthetics to perform adductor canal block will reduce pain scale and opioid consumption in patients receiving total knee arthroplasty compared with longer interval bolus of local anesthetics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05518513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bupivacain
Trials testing the same drug.
- NCT07429448 — Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Pa · Phase 1 · recruiting
- NCT07292324 — Continuous Epidural With Dexmedetomidine Adjuvant in Gynecologic Laparotomy · Phase 4 · completed
- NCT07274670 — Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery · NA · completed
- NCT06935669 — Analgesic Effect of Bupivacaine Plus Ketamine Versus Bupivacaine Alone in Transversalis Fascia Plane Block · Phase 1 · not yet recruiting
- NCT06856538 — Rhomboid Intercostal Sub Serratus Plane Block Versus Serratus Anterior Plane Block in Thoractomy · NA · recruiting
Other recruiting trials for Arthroplasty, Replacement, Knee
Currently open trials in the same condition.
- NCT07337772 — Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty · NA · recruiting
- NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting
- NCT05992064 — Wearable Sensors for Monitoring Recovery After Total Knee Arthroplasty · recruiting
- NCT04884542 — Multigen Plus H Study and AMF TT Cones · recruiting
- NCT03078543 — Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System · active not recruiting
Other National Cheng-Kung University Hospital trials
Trials by the same sponsor.
- NCT07525713 — Virtual Reality Mirror Therapy With Focused Object-Directed Attention System · NA · not yet recruiting
- NCT07369271 — Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery · NA · not yet recruiting
- NCT07262411 — Peer-based Recovery Program · NA · not yet recruiting
- NCT07257926 — Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients: A Randomized Contr · Phase 4 · not yet recruiting
- NCT07269132 — Applying the ADDIE Model to Develop a Multimedia Program to Enhance Chemotherapy Knowledge and Self-Efficacy Among Inten · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05518513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cheng-Kung University Hospital
- Last refreshed: 5 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05518513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing